股本结构
单位：万股
| 公告日期 | 2025-11-12 | 2025-10-31 | 2025-10-31 | 2025-09-29 | 2025-08-05 | 2025-08-05 |
|---|---|---|---|---|---|---|
| 证券总股本 | 7584.72 | 7584.46 | 7584.09 | 7578.44 | 7563.44 | 7556.51 |
| 普通股本 | 7584.72 | 7584.46 | 7584.09 | 7578.44 | 7563.44 | 7556.51 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-11-11 | 2025-10-26 | 2025-09-30 | 2025-09-25 | 2025-07-29 | 2025-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-12 | 7584.72 | 未披露 | 定期报告 | 2025-11-11 |
| 2025-10-31 | 7584.46 | 未披露 | 定期报告 | 2025-10-26 |
| 2025-10-31 | 7584.09 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Exercise of stock options and vesting of restricted stock units
|
2025-09-30 |
| 2025-09-29 | 7578.44 | 未披露 | 定期报告 | 2025-09-25 |
| 2025-08-05 | 7563.44 | 未披露 | 定期报告 | 2025-07-29 |
| 2025-08-05 | 7556.51 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Exercise of share options and vesting of restricted share units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
|
2025-06-30 |
| 2025-06-05 | 7447.67 | 未披露 |
更多>>
Common stock offered 5,263,158 shares by the company
|
2025-06-05 |
| 2025-05-07 | 6921.36 | 未披露 | 定期报告 | 2025-04-30 |
| 2025-04-24 | 6918.33 | 未披露 | 定期报告 | 2025-04-23 |
| 2025-04-24 | 6918.33 | 未披露 | 定期报告 | 2025-04-18 |
| 2025-05-07 | 6917.58 | 未披露 |
更多>>
From January 1, 2025 to March 31, 2025
Exercise of share options and vesting of restricted share units
|
2025-03-31 |
| 2025-02-27 | 6909.05 | 未披露 | 定期报告 | 2025-02-21 |
| 2025-02-27 | 6882.87 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Issuance of common share - Gilead
Exercise of share options and vesting of restricted share units
Issuance of common share in connection with public offerings, net of underwriting discounts and commissions and offering costs
|
2024-12-31 |
| 2024-10-31 | 6846.37 | 未披露 | 定期报告 | 2024-10-27 |
| 2024-10-31 | 6842.68 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Exercise of stock options and vesting of restricted stock units
|
2024-09-30 |
| 2024-08-01 | 6821.05 | 未披露 | 定期报告 | 2024-07-25 |
| 2024-08-01 | 6785.29 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Exercise of share options and vesting of restricted share units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
|
2024-06-30 |
| 2024-05-30 | 6737.01 | 未披露 |
更多>>
Common stock offered 7,550,000 shares by the company
|
2024-05-31 |
| 2024-05-30 | 5982.01 | 未披露 |
更多>>
Merus N.V. also granted the Underwriters an option exercisable for 30 days to purchase up to an additional 1,132,500 common shares at the public offering price
|
2024-05-30 |
| 2024-05-08 | 5868.76 | 未披露 |
更多>>
From January 1, 2024 to March 31, 2024
Exercise of share options and vesting of restricted share units
Issuance of common share - Gilead
|
2024-03-31 |
| 2024-04-10 | 5865.03 | 未披露 | 定期报告 | 2024-03-15 |
| 2024-02-28 | 5787.83 | 未披露 | 定期报告 | 2024-02-22 |
| 2024-02-28 | 5782.59 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Exercise of stock options and vesting of restricted stock units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
|
2023-12-31 |
| 2023-11-02 | 5773.28 | 未披露 | 定期报告 | 2023-10-30 |
| 2023-11-02 | 5772.92 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Exercise of stock options and vesting of restricted stock units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
|
2023-09-30 |
| 2023-08-11 | 5667.77 | 未披露 |
更多>>
Common shares offered 6,818,182 common shares by the company
|
2023-08-14 |
| 2023-08-07 | 4985.95 | 未披露 | 定期报告 | 2023-07-31 |
| 2023-08-07 | 4985.37 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Exercise of stock options and vesting of restricted stock units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
|
2023-06-30 |
| 2023-04-28 | 4653.09 | 未披露 | 定期报告 | 2023-04-27 |
| 2023-05-04 | 4634.12 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Exercise of stock options and vesting of restricted stock units
|
2023-03-31 |
| 2023-02-28 | 4631.73 | 未披露 | 定期报告 | 2023-02-22 |
| 2023-02-28 | 4631.06 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Exercise of stock options and vesting of restricted stock units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
|
2022-12-31 |
| 2022-11-03 | 4630.29 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Exercise of stock options and vesting of restricted stock units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
|
2022-09-30 |
| 2022-08-08 | 4587.82 | 未披露 | 定期报告 | 2022-08-01 |
| 2022-08-08 | 4586.68 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
Exercise of stock options and vesting of restricted stock units
|
2022-06-30 |
| 2022-04-29 | 4355.01 | 未披露 | 定期报告 | 2022-04-28 |
| 2022-05-09 | 4354.93 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Exercise of stock options and vesting of restricted stock units
|
2022-03-31 |
| 2022-02-28 | 4347.71 | 未披露 | 定期报告 | 2022-02-21 |
| 2022-02-28 | 4346.71 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock, net
Issuance of common stock - Lilly
Exercise of stock options and vesting of restricted stock units
|
2021-12-31 |
| 2021-11-09 | 4267.16 | 未披露 |
更多>>
1.Common shares to be offered by company 3,859,650 common shares.
2.The number of common shares to be outstanding after this offering is based on 38,811,963 common shares outstanding as of October 31, 2021.
|
2021-11-09 |
| 2021-11-04 | 3881.20 | 未披露 | 定期报告 | 2021-10-31 |
| 2021-11-02 | 3880.75 | 未披露 | 定期报告 | 2021-10-29 |
| 2021-11-02 | 3860.51 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of stock options and vesting of restricted stock units
|
2021-09-30 |
| 2021-08-05 | 3847.78 | 未披露 | 定期报告 | 2021-07-30 |
| 2021-08-05 | 3844.46 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of stock options and vesting of restricted stock units
|
2021-06-30 |
| 2021-04-29 | 3834.96 | 未披露 | 定期报告 | 2021-04-28 |
| 2021-04-29 | 3832.33 | 未披露 | 定期报告 | 2021-04-15 |
| 2021-05-06 | 3827.16 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of common stock, net
Issuance of common stock - Lilly
Exercise of stock options and vesting of restricted stock units
|
2021-03-31 |
| 2021-03-16 | 3812.70 | 未披露 | 定期报告 | 2021-02-28 |
| 2021-01-25 | 3715.83 | 未披露 |
更多>>
1.Common shares to be offered by the company 4,848,485 shares.
2.The number of common shares to be outstanding after this offering is based on 31,602,953 common shares outstanding as of December 31, 2020.
|
2021-01-25 |
| 2021-03-16 | 3160.30 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of common stock, net
Exercise of stock options and vesting of restricted stock units
|
2020-12-31 |
| 2020-11-05 | 2908.87 | 未披露 | 定期报告 | 2020-10-30 |
| 2020-11-05 | 2907.45 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Exercise of stock options and vesting of restricted stock units
|
2020-09-30 |
| 2020-08-06 | 2905.71 | 未披露 | 定期报告 | 2020-08-03 |
| 2020-08-06 | 2904.73 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Exercise of stock options and vesting of restricted stock units
|
2020-06-30 |
| 2020-06-02 | 2904.15 | 未披露 | 定期报告 | 2020-06-02 |
| 2020-06-02 | 2903.99 | 未披露 | 定期报告 | 2020-05-27 |
| 2020-05-11 | 2903.59 | 未披露 | 定期报告 | 2020-04-30 |
| 2020-04-29 | 2901.35 | 未披露 | 定期报告 | 2020-04-07 |
| 2020-05-11 | 2900.94 | 未披露 |
更多>>
From January 1, 2020 to March 31, 2020
Exercise of stock options and vesting of restricted stock units
|
2020-03-31 |
| 2020-03-16 | 2900.30 | 未披露 | 定期报告 | 2020-02-28 |
| 2020-03-16 | 2888.22 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Issuance of common stock, net
Exercise of stock options and vesting of restricted stock units
|
2019-12-31 |
| 2019-11-07 | 2815.76 | 未披露 | 定期报告 | 2019-11-07 |
| 2019-11-12 | 2340.76 | 未披露 |
更多>>
from January 1, 2019 to September 30, 2019
Exercise of common share options
Vesting of RSUs
|
2019-09-30 |
| 2019-08-19 | 2339.33 | 未披露 |
更多>>
from January 1, 2019 to June 30, 2019
Exercise of common share options
Vesting of RSUs
|
2019-06-30 |
| 2019-05-30 | 2337.97 | 未披露 |
更多>>
from January 1, 2019 to March 31, 2019
Exercise of common share options
Vesting of RSUs
|
2019-03-31 |
| 2019-04-03 | 2335.90 | 未披露 |
更多>>
from January 1, 2018 to December 31, 2018
Issuance of shares (net)
|
2018-12-31 |
| 2018-12-27 | 2273.46 | 未披露 |
更多>>
from January 1, 2018 to September 30, 2018
Issuance of shares (net)
|
2018-09-30 |
| 2018-08-10 | 2263.28 | 未披露 |
更多>>
from January 1, 2018 to June 30, 2018
Issuance of shares (net)
|
2018-06-30 |
| 2018-05-15 | 2262.06 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-04-30 | 1942.98 | 未披露 | 定期报告 | 2017-12-31 |
| 2017-12-01 | 1940.96 | 未披露 |
更多>>
from January 1, 2017 to September 30, 2017
Issuance of shares (net)
|
2017-09-30 |
| 2017-09-22 | 1939.67 | 未披露 |
更多>>
from January 1, 2017 to June 30, 2017
Issuance of shares (net)
|
2017-06-30 |
| 2017-06-01 | 1939.23 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-04-28 | 1608.59 | 未披露 |
更多>>
from January 1, 2016 to December 31, 2016
Transactions with owners of the Company:
Issuance of shares (net)
Conversion preference shares
On 6 May 2016, the general meeting of shareholders of the Company resolved to approve and effect a capital reorganization, based on a reverse share split. The effect of the reverse share split was a 1-for-1.8 reverse share split of the outstanding common and preferred shares held by the Company’s shareholders. This reverse share split became effective on 6 May 2016. All share, per-share and related information presented in the interim financial statements and corresponding disclosure notes have been retrospectively adjusted, where applicable, to reflect the impact of the reverse share split.
|
2016-12-31 |
| 2016-11-07 | 1607.97 | 未披露 |
更多>>
from January 1, 2016 to September 30, 2016
Transactions with owners of the Company:
Issuance of shares (net)
Conversion preference shares
On 6 May 2016, the general meeting of shareholders of the Company resolved to approve and effect a capital reorganization, based on a reverse share split. The effect of the reverse share split was a 1-for-1.8 reverse share split of the outstanding common and preferred shares held by the Company’s shareholders. This reverse share split became effective on 6 May 2016. All share, per-share and related information presented in the interim financial statements and corresponding disclosure notes have been retrospectively adjusted, where applicable, to reflect the impact of the reverse share split.
|
2016-09-30 |
| 2016-05-20 | 1540.71 | 未披露 |
更多>>
The automatic conversion of all of our outstanding preferred shares at April 30, 2016 into an aggregate of 8,278,043 common shares in connection with this offering;
The issuance of 1,279,396 common shares to the holders of our Class B and C preferred shares in connection with this offering in satisfaction of their entitlement to distributions in kind accrued as of April 30, 2016, all of which is described in more detail in “Capitalization—Preferred Share Distributions”;
A 1-for-1.80 reverse share split of our common and preferred shares that was effected on May 6, 2016.
|
2016-05-19 |
| 2016-05-20 | 990.71 | 未披露 | 定期报告 | 2016-04-30 |
From June 30, 2025 to September 30, 2025
Exercise of stock options and vesting of restricted stock units
From March 31, 2025 to June 30, 2025
Exercise of share options and vesting of restricted share units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
Common stock offered 5,263,158 shares by the company
From January 1, 2025 to March 31, 2025
Exercise of share options and vesting of restricted share units
From December 31, 2023 to December 31, 2024
Issuance of common share - Gilead
Exercise of share options and vesting of restricted share units
Issuance of common share in connection with public offerings, net of underwriting discounts and commissions and offering costs
From June 30, 2024 to September 30, 2024
Exercise of stock options and vesting of restricted stock units
From March 31, 2024 to June 30, 2024
Exercise of share options and vesting of restricted share units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
Common stock offered 7,550,000 shares by the company
Merus N.V. also granted the Underwriters an option exercisable for 30 days to purchase up to an additional 1,132,500 common shares at the public offering price
From January 1, 2024 to March 31, 2024
Exercise of share options and vesting of restricted share units
Issuance of common share - Gilead
From December 31, 2022 to December 31, 2023
Exercise of stock options and vesting of restricted stock units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
From June 30, 2023 to September 30, 2023
Exercise of stock options and vesting of restricted stock units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
Common shares offered 6,818,182 common shares by the company
From March 31, 2023 to June 30, 2023
Exercise of stock options and vesting of restricted stock units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
From January 1, 2023 to March 31, 2023
Exercise of stock options and vesting of restricted stock units
From December 31, 2021 to December 31, 2022
Exercise of stock options and vesting of restricted stock units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
From June 30, 2022 to September 30, 2022
Exercise of stock options and vesting of restricted stock units
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
From March 31, 2022 to June 30, 2022
Issuance of common stock in connection with public offerings, net of underwriting discounts and commissions and offering costs
Exercise of stock options and vesting of restricted stock units
From January 1, 2022 to March 31, 2022
Exercise of stock options and vesting of restricted stock units
From December 31, 2020 to December 31, 2021
Issuance of common stock, net
Issuance of common stock - Lilly
Exercise of stock options and vesting of restricted stock units
1.Common shares to be offered by company 3,859,650 common shares.
2.The number of common shares to be outstanding after this offering is based on 38,811,963 common shares outstanding as of October 31, 2021.
From June 30, 2021 to September 30, 2021
Exercise of stock options and vesting of restricted stock units
From March 31, 2021 to June 30, 2021
Exercise of stock options and vesting of restricted stock units
From December 31, 2020 to March 31, 2021
Issuance of common stock, net
Issuance of common stock - Lilly
Exercise of stock options and vesting of restricted stock units
1.Common shares to be offered by the company 4,848,485 shares.
2.The number of common shares to be outstanding after this offering is based on 31,602,953 common shares outstanding as of December 31, 2020.
From December 31, 2019 to December 31, 2020
Issuance of common stock, net
Exercise of stock options and vesting of restricted stock units
From June 30, 2020 to September 30, 2020
Exercise of stock options and vesting of restricted stock units
From March 31, 2020 to June 30, 2020
Exercise of stock options and vesting of restricted stock units
From January 1, 2020 to March 31, 2020
Exercise of stock options and vesting of restricted stock units
From December 31, 2018 to December 31, 2019
Issuance of common stock, net
Exercise of stock options and vesting of restricted stock units
from January 1, 2019 to September 30, 2019
Exercise of common share options
Vesting of RSUs
from January 1, 2019 to June 30, 2019
Exercise of common share options
Vesting of RSUs
from January 1, 2019 to March 31, 2019
Exercise of common share options
Vesting of RSUs
from January 1, 2018 to December 31, 2018
Issuance of shares (net)
from January 1, 2018 to September 30, 2018
Issuance of shares (net)
from January 1, 2018 to June 30, 2018
Issuance of shares (net)
from January 1, 2017 to September 30, 2017
Issuance of shares (net)
from January 1, 2017 to June 30, 2017
Issuance of shares (net)
from January 1, 2016 to December 31, 2016
Transactions with owners of the Company:
Issuance of shares (net)
Conversion preference shares
On 6 May 2016, the general meeting of shareholders of the Company resolved to approve and effect a capital reorganization, based on a reverse share split. The effect of the reverse share split was a 1-for-1.8 reverse share split of the outstanding common and preferred shares held by the Company’s shareholders. This reverse share split became effective on 6 May 2016. All share, per-share and related information presented in the interim financial statements and corresponding disclosure notes have been retrospectively adjusted, where applicable, to reflect the impact of the reverse share split.
from January 1, 2016 to September 30, 2016
Transactions with owners of the Company:
Issuance of shares (net)
Conversion preference shares
On 6 May 2016, the general meeting of shareholders of the Company resolved to approve and effect a capital reorganization, based on a reverse share split. The effect of the reverse share split was a 1-for-1.8 reverse share split of the outstanding common and preferred shares held by the Company’s shareholders. This reverse share split became effective on 6 May 2016. All share, per-share and related information presented in the interim financial statements and corresponding disclosure notes have been retrospectively adjusted, where applicable, to reflect the impact of the reverse share split.
The automatic conversion of all of our outstanding preferred shares at April 30, 2016 into an aggregate of 8,278,043 common shares in connection with this offering;
The issuance of 1,279,396 common shares to the holders of our Class B and C preferred shares in connection with this offering in satisfaction of their entitlement to distributions in kind accrued as of April 30, 2016, all of which is described in more detail in “Capitalization—Preferred Share Distributions”;
A 1-for-1.80 reverse share split of our common and preferred shares that was effected on May 6, 2016.